144 related articles for article (PubMed ID: 34732086)
1. High-intensity focused ultrasound ablation as an adjuvant surgical salvage procedure in gestational trophoblastic neoplasia chemotherapy with chemoresistance or recurrence: two case reports.
She C; Li S; Wang X; Lu X; Liang H; Liu X
Int J Hyperthermia; 2021; 38(1):1584-1589. PubMed ID: 34732086
[TBL] [Abstract][Full Text] [Related]
2. High-intensity focused ultrasound as a pretreatment combined with hysteroscopic resection for gestational trophoblastic neoplasia with chemotherapy intolerance: a case report.
Liu Y; Huang J; Du C; Jiang J; Zhou H; Qu D
Int J Hyperthermia; 2023; 40(1):2192448. PubMed ID: 36966804
[TBL] [Abstract][Full Text] [Related]
3. Long-term outcome of ultrasound-guided focused ultrasound ablation for gestational trophoblastic neoplasia in the cesarean scar: a case report.
Qu D; Chen Y; Jiang J; Shi Q; Zhou H; Wang Z
BMC Womens Health; 2022 Dec; 22(1):522. PubMed ID: 36522625
[TBL] [Abstract][Full Text] [Related]
4. Treatment of extremely high risk and resistant gestational trophoblastic neoplasia patients in King Chulalongkorn Memorial Hospital.
Oranratanaphan S; Lertkhachonsuk R
Asian Pac J Cancer Prev; 2014; 15(2):925-8. PubMed ID: 24568520
[TBL] [Abstract][Full Text] [Related]
5. Predictors of chemotherapy resistance & relapse in gestational trophoblastic neoplasia.
Singhal S; Kumar L; Kumar S; Khurana S; Bhatla N
Indian J Med Res; 2020 Dec; 152(6):595-606. PubMed ID: 34145099
[TBL] [Abstract][Full Text] [Related]
6. Role of salvage therapy in chemo resistant or recurrent high-risk gestational trophoblastic neoplasm.
Anantharaju AA; Pallavi VR; Bafna UD; Rathod PS; R VC; K S; Kundargi R
Int J Gynecol Cancer; 2019 Mar; 29(3):547-553. PubMed ID: 30700567
[TBL] [Abstract][Full Text] [Related]
7. Analysis of Clinical Characteristics and Outcomes in 7 Patients with Re-recurrent Gestational Trophoblastic Neoplasia.
Li B; Wan X; Liang Y; Lu B; Lu W
J Reprod Med; 2016 Sep; 61(9-10):494-502. PubMed ID: 30383951
[TBL] [Abstract][Full Text] [Related]
8. Pulmonary Resection in the Management of High-Risk Gestational Trophoblastic Neoplasia.
Kanis MJ; Lurain JR
Int J Gynecol Cancer; 2016 May; 26(4):796-800. PubMed ID: 26905332
[TBL] [Abstract][Full Text] [Related]
9. The added value of hysterectomy in the management of gestational trophoblastic neoplasia.
Eysbouts YK; Massuger LFAG; IntHout J; Lok CAR; Sweep FCGJ; Ottevanger PB
Gynecol Oncol; 2017 Jun; 145(3):536-542. PubMed ID: 28390821
[TBL] [Abstract][Full Text] [Related]
10. Management of relapsed gestational trophoblastic neoplasia: What can help to reduce the re-recurrence rate?
Wang X; Cheng Y; Li W; Mao R; Zhu T; Lu J; Yue X; Lu X
J Obstet Gynaecol Res; 2022 Jun; 48(6):1451-1457. PubMed ID: 35289459
[TBL] [Abstract][Full Text] [Related]
11. Effect of lung metastasis on the treatment and prognosis of patients with gestational trophoblastic neoplasia: A systematic review and meta-analysis.
Zhang T; Guo Y; He X; Hou M; Wang L; An R; Gao L
Acta Obstet Gynecol Scand; 2024 Apr; 103(4):636-644. PubMed ID: 38282348
[TBL] [Abstract][Full Text] [Related]
12. Management and risk factors of recurrent gestational trophoblastic neoplasia: An update from 2004 to 2017.
Kong Y; Zong L; Cheng H; Jiang F; Wan X; Feng F; Ren T; Zhao J; Yang J; Xiang Y
Cancer Med; 2020 Apr; 9(7):2590-2599. PubMed ID: 32022487
[TBL] [Abstract][Full Text] [Related]
13. Chemotherapy for resistant or recurrent gestational trophoblastic neoplasia.
Alazzam M; Tidy J; Osborne R; Coleman R; Hancock BW; Lawrie TA
Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD008891. PubMed ID: 26760424
[TBL] [Abstract][Full Text] [Related]
14. Chemotherapy for resistant or recurrent gestational trophoblastic neoplasia.
Alazzam M; Tidy J; Osborne R; Coleman R; Hancock BW; Lawrie TA
Cochrane Database Syst Rev; 2012 Dec; 12():CD008891. PubMed ID: 23235667
[TBL] [Abstract][Full Text] [Related]
15. [Clinical analysis of patients with relapsed and chemo-resistant gestational trophoblastic neoplasia].
Zhou Y; Feng FZ; Xiang Y; Wan XR
Zhonghua Fu Chan Ke Za Zhi; 2010 Nov; 45(11):804-7. PubMed ID: 21211275
[TBL] [Abstract][Full Text] [Related]
16. Treatment of high-risk gestational trophoblastic neoplasia and chemoresistance/relapsed disease.
Braga A; Elias KM; Horowitz NS; Berkowitz RS
Best Pract Res Clin Obstet Gynaecol; 2021 Jul; 74():81-96. PubMed ID: 33622563
[TBL] [Abstract][Full Text] [Related]
17. Importance of salvage therapy in the management of high-risk gestational trophoblastic neoplasia.
Lurain JR; Schink JC
J Reprod Med; 2012; 57(5-6):219-24. PubMed ID: 22696816
[TBL] [Abstract][Full Text] [Related]
18. [Preliminary study of PD-1 inhibitor in the treatment of drug-resistant recurrent gestational trophoblastic neoplasia].
Cheng HY; Yang JJ; Zhao J; Ren T; Feng FZ; Wan XR; Xiang Y
Zhonghua Fu Chan Ke Za Zhi; 2020 Jun; 55(6):390-394. PubMed ID: 32842245
[No Abstract] [Full Text] [Related]
19. When to stop human chorionic gonadotrophin (hCG) surveillance after treatment with chemotherapy for gestational trophoblastic neoplasia (GTN): A national analysis on over 4,000 patients.
Balachandran K; Salawu A; Ghorani E; Kaur B; Sebire NJ; Short D; Harvey R; Hancock B; Tidy J; Singh K; Sarwar N; Winter MC; Seckl MJ
Gynecol Oncol; 2019 Oct; 155(1):8-12. PubMed ID: 31375268
[TBL] [Abstract][Full Text] [Related]
20. Role of immune checkpoint inhibitors combined with chemotherapy in recurrent drug-resistant gestational trophoblastic neoplasia: Four case reports and literature review.
Liu W; Zhu Y; Wang Y; Li R; Zou D; Chen R; Yang L; Huang Y
Cancer Rep (Hoboken); 2024 Mar; 7(3):e2016. PubMed ID: 38425251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]